The Medtronic Sprint Fidelis Lead Advisory Notification has no adverse impact on patient reported outcomes in Danish implantable cardioverter defibrillator patients.

Susanne Møller Pedersen, Henneke Versteeg, Jens C. Nielsen, Peter T. Mortensen, Jens Brock Johansen

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceForskning

Abstrakt

The Medtronic Sprint Fidelis Lead Advisory Notification has no adverse impact on patient reported outcomes in Danish implantable cardioverter defibrillator patients.
OriginalsprogEngelsk
Publikationsdato2011
Antal sider1
StatusUdgivet - 2011
BegivenhedEuropean Heart Rhythm Association - Madrid, Spanien, Madrid, Spanien
Varighed: 26. jun. 201129. jun. 2011

Konference

KonferenceEuropean Heart Rhythm Association
LokationMadrid, Spanien
LandSpanien
ByMadrid
Periode26/06/201129/06/2011

Bibliografisk note

Europace (2011) 13 (suppl 3):NP.doi:10.1093/europace/eur222.

Citationsformater